Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Head and Neck Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Melanoma 2Lung Neoplasms 2Liver Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Sarcoma 1Recurrence 1Precancerous Conditions 1Pharyngeal Neoplasms 1Peritoneal Neoplasms 1Paranasal Sinus Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Laryngeal Neoplasms 1Glioblastoma 1Colonic Neoplasms 1Breast Neoplasms 1Biomarker Change Linked to Breast Cancer 1

Interventions

Vitamin D 1Cholecalciferol 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Biomarker Change Linked to Breast Cancer × Celecoxib × Clear all
NCT01769625 2017-08-09

Changes in Biomarkers Using Prostaglandin Inhibitors

Hartford Hospital

Phase 1/2 Completed
31 enrolled
Breast

Biomarker Change Linked to Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡